Anna joined SEB Venture Capital in 2006 from the Invest in Sweden Agency, where she was international sales and business development manager responsible for the North American market, specialising in life science. Anna obtained her PhD in Molecular Biotechnology from the Royal Institute of Technology and has published eleven articles in peer-reviewed international scientific journals. She has also held a position at Astra Zeneca in CNS R&D and earned her M.S. in Molecular Biology from the Stockholm University, Karolinska Institute and Imperial College.
After playing football for ten years, Anna has now hung up her boots but remains an avid supporter of her favourite club, Hammarby.